MoneyWorks4Me

Auro Laboratories informs about quarterly statement on investor complaints

11 Jan 2017 Evaluate

Auro Laboratories has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1738.05
Dr. Reddys Labs. 1241.55
Cipla 1319.00
Lupin 1945.80
Zydus Lifesciences 1115.15
View more..